Clinician Scientist

Masoom Haider

Medical Imaging, Radiology

MD

mahaider@radfiler.com

Location

Mount Sinai Hospital

Research Interests

Magnetic resonance imaging (MRI), Computed tomography (CT), Radiomics, Quantitative imaging biomarkers, Prostate Cancer, Pancreatic Cancer, Renal Cell Carcinoma, Liver Metastases, Hepatocellular Carcinoma, Computer-Aided Diagnosis

Dr. Masoom Haider is a radiologist and clinician scientist at the University of Toronto in the Joint Department of Medical Imaging. His research focuses on image biomarker validation using multiparametric MRI and CT technologies.

His team uses machine learning and artificial intelligence methods combined with imaging biomarkers to develop predictive and prognostic radiomics signatures for pelvic cancers, including prostate, pancreas, kidney and liver cancers.

Dr. Haider is the imaging lead on national MRI trials in prostate cancer and has worked on guideline development for the use of multiparametric prostate MRI (mpMRI) for prostate cancer, namely the Pi-Rads standard. He holds a Chair in Artificial Intelligence, Imaging Biomarkers and Radiomics at the Lunenfeld-Tanenbaum Research Institute, Sinai Health System. In the Joint Department of Medical Imaging and Lunenfeld-Tanenbaum Research Institute he leads the AI, Radiomics and Oncologic Imaging Research Lab and collaborates with oncologists, computer scientists, engineers, radiologists and biomedical physicists.